A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will ...

Euro US Dollar, British Pound US Dollar, US Dollar Japanese Yen, Australian Dollar US Dollar. Read 's Market Analysis on Investing.com ...

Novo Nordisk’s weight loss drug, Wegovy, is experiencing a surge in new prescriptions following a US ban on its copycat ...

Novo Nordisk A/S (NYSE: NVO) is one of the top low volatility healthcare stocks to buy now. In a report released on July 17, ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Novo Nordisk A/S (NYSE:NVO) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 18, Novo Nordisk A/S ...

Goldman Sachs GQG Partners International Opportunities GSIMX has the elements in place to continue to outperform, though the road could be bumpy at times.

Aging America may revive healthcare stocks after a rough year — discover why long-term trends point to a powerful rebound.

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

Novo Nordisk trades at a significant discount to Eli Lilly, offering nearly 38% upside. Click here to find out why NVO stock ...

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

Alberto Conca, CIO at Swiss wealth manager LFG+ZEST, has been adding exposure to pharma, biotech and medtech in recent weeks, drawn by strong cash-flow yields and the prospect of U.S. rate cuts ...